On Friday, the one highly active penny stock of MusclePharm Corp. (OTC: MSLP) set a new YTD high after closing at $9.90. MSLP stock gained 20.73% on Friday ending the day as the 15th most traded stock on the OTC with dollar volume of $3,333,978, share volume of 367,349 after 496 executed trades were processed. As users of the Company’s products and avid followers of their trading activity, up roughly 200% from their YTD lows from January,Friday’s price action looks to be the beginning of something big.
Another penny stock focused on nutritional supplements, Creative Edge Nutrition, Inc. (OTC: FITX), seeks to gain some exposure this week and market how they utilize the latest advancements in weight loss technology in their products. The awareness is set to begin at the opening bell with traders getting a chance to get their hands on FITX stock, likely above the YTD high after the gap open. With a GNC number announced over a month ago, the Company’s products should soon be on the same shelves where MusclePharm products are. One benefit they have, at least for today, is the entry into the Medical Marijuana sector – a sure fire win and virtual guarantee to set a new YTD high today.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
FITX Stock Quote
Market Cap: 3.91M
Last: .0058 ▼ -0.0001 (-1.69%)
Issued and Outstanding: 673,586,780
1st Resistance Point: 0.0063
1st Support Level: 0.0055
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
Although Creative Edge Nutrition, Inc. is not yet an SEC filing Company, the reported numbers from their most recent period ended December 31, 2012 are not all that bad. The Company has followed the path of other industry winners like MusclePharm by developing five product categories to enhance performance, according to the targeted customer’s lifestyle:
- LEAN – Weight loss
- ENERGY – Metabolic enhancement
- ESSENTIALS – Fast and efficient recovery / well-being
- MASS – Muscle enhancement and stimulation
- APPAREL- Cenergy’s apparel line is both functional and fashionable
Last fiscal year ended September 30, 2012, Creative Edge Nutrition nearly squeezed out net income. Net loss for the year ended was just ($619,771) off of revenues of $2.153,331. Last quarter ended December 31, 2012, the Company booked sales of $774,644 – on pace to surpass by more than 30% their prior 12 months sales numbers.
Prior to the open today, Creative Edge Nutrition announced their entry into the hottest sector for a penny stock — Medical Marijuana. The Company announced the move via Hemp Protein Powder, our Naturals Line, Hemp-plex and Chia-plex.
One of the top reasons to potentially switch to hemp protein powder is that it’s not made from a processed milk product – superb news for all of those lactose intolerant, health conscious customers whom have difficulty when it comes to digesting whey or casein protein powders.
While FITX stock has seen limited action thus far in 2013, today should set new records for volume, to say the least. Expectations are for FITX stock to see some immeasurable attention prior to the open setting the table for a huge gap which could, as many know already, trap early traders into positions which force further trades to average down later on.
About FITX Stock
Creative Edge Nutrition, Inc. is a development stage company focused on building a customer brand loyalty by developing a diverse portfolio of health oriented nutrition products.
20 Day Moving Average: 0.0059
20 Day Average Volume: 3,690,745
Last 5 Trading Sessions:
Bottom Line: FITX may not be the greatest penny stock traded today, but savvy traders skip the gap open before jumping in for a day trade should see some good swings. After today, its hard to tell whether or not the newest of the marijuana stocks, FITX stock, can hold its gains for more than a few days before eventually pulling back some. That said, look for them to, one day down the road, prepare the essential documentation in order to uplist to the OTCBB making their sub penny status a worthy addition tot he watch list long term.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share